Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France

Marie‐Laure Laroche, Marion Labetoulle, Emilie Jouanjus, Edeltraut Kröger, Arsène Zongo

Open source

DOI
10.1111/fcp.70028
Published
2025-06-20
Container
Fundamental & Clinical Pharmacology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/fcp.70028,
  title = {Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France},
  author = {Marie‐Laure Laroche and Marion Labetoulle and Emilie Jouanjus and Edeltraut Kröger and Arsène Zongo},
  year = {2025},
  journal = {Fundamental \& Clinical Pharmacology},
  doi = {10.1111/fcp.70028},
  url = {https://doi.org/10.1111/fcp.70028}
}

RIS

TY  - JOUR
TI  - Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France
AU  - Marie‐Laure Laroche
AU  - Marion Labetoulle
AU  - Emilie Jouanjus
AU  - Edeltraut Kröger
AU  - Arsène Zongo
PY  - 2025
JO  - Fundamental & Clinical Pharmacology
DO  - 10.1111/fcp.70028
UR  - https://doi.org/10.1111/fcp.70028
ER  - 

APA

Laroche, M., Labetoulle, M., Jouanjus, E., Kröger, E., & Zongo, A. (2025). Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.70028

Source records